MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

(00:31):Before we get started, Dr. Halling, could you provide us with a little bit about you and your background? (01:11):Would you like to give us a basic summary of this test?(02:43):So in talking about patients, can you tell us which patients should have this testing? And when it is typically performed? (05:01):Do you want to talk about some of the guidelines that were used to shape the genes included in this panel? (05:36):Can you tell us a bit about the alternative test options that are available and how they compare to this large panel? (06:42):So I know most other panels on the market assess for mutations and fusions. Is there a reason why our panel also looks at amplifications and are certain subset of the genes? (07:29):So do you want to talk about how this panel offers some benefits over other large panels in the market? (08:46):Let's talk a little bit about how the results of this test can be used in patient care.